Conference Detail Page

Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study

CME : 0.75
Start Date :  Sep 08 - 2020 End Date :  Sep 08 - 2023

Organized by :   American Academy of Neurology (AAN)

Specialities :   Neurology, Cardiology, Psychiatry, Genetics

Conference Summary

Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study is organized by American Academy of Neurology (AAN).

Dates:
Released: 9/8/2020
Expires: 9/8/2023

Accreditation:
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:
Upon completion of the article by Peloso et al., the participant should be able to:
• Discuss how the genetic risk score (GRS) was calculated in this study
• List clinical factors that differed significantly between patients with incident dementia and those who did not develop dementia in this study
• Discuss the effect of moving from unfavorable to favorable cardiovascular health for patients with a high GRS and subjects with at least one ApoE4 allele in this study

Topic
Dementia
Dementia
Credit Info

  • CME : 0.75
Target Audience

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

Peers Info
Number of Health Care Professionals Registered: 0 Number
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat